Physician profile
Maggie E Narrigan
NPI 1205010725
$2,732.37
in general payments reported to CMS, 2019-2025
11 companies · $468 in 2025
The $468 reported for 2025 was more than what 79% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $18.59 · 2023: $1,351 · 2024: $895 · 2025: $468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,200 · Travel and Lodging: $479 · Gift: $34.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,200.48 |
| Travel and Lodging | $478.96 |
| Gift | $34.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,192.86 | 2023-2024 | Da Vinci Surgical System |
| Sanofi-Aventis U.S. LLC | $240.85 | 2023-2025 | |
| Neurelis, INC. | $222.55 | 2025 | Valtoco |
| Abbvie INC. | $212.12 | 2023 | |
| Hologic Sales and Service, LLC | $148.01 | 2024 | Aptima |
| Intrinsic Therapeutics | $136.82 | 2024 | Barricaid Acd (Annular Closure Device) |
| Grifols USA, LLC | $131.30 | 2024 | Prolastin-C Liquid |
| Edwards Lifesciences Corporation | $128.15 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Actelion Pharmaceuticals US, INC. | $117.76 | 2025 | Uptravi, Opsumit |
| Bayer Healthcare Pharmaceuticals INC. | $104.32 | 2023 | |
| Kci USA, INC. | $97.63 | 2022-2023 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Maggie Narrigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.